Sheikha Anwar K, Salih Ziyan T, Kasnazan Kalandar H, Khoshnaw Mohammad K, Al-Maliki Talal, Al-Azraqi Tarek A, Zafer Mubarak H
Department of Pathology, University of Mississippi Medical Center, Jackson, Miss. 39216, USA.
Can J Surg. 2007 Oct;50(5):382-6.
We aimed to evaluate the protective role of partial versus total splenectomy against sepsis in patients with thalassaemia when other preventive measures are not available. Overwhelming postsplenectomy infection is a serious complication of splenectomy in these patients, and most present with pneumococcal septicemia. Pneumococcal vaccine given before surgery is a well-established preventive measure.
In this study, we compared 2 populations of patients from Iraq and Saudi Arabia, both of whom underwent splenectomy for thalassaemia. All patients from Saudi Arabia were given a preoperative pneumococcal vaccine and underwent total splenectomy after about 4 weeks. Unfortunately, this vaccine was not available for the Iraqi patients. Partial splenectomy was offered to many of these patients as a protective measure against this fatal complication.
A significant difference was found between the total splenectomy fatalities in the 2 groups. There were 5 deaths in the 30 enrolled Iraqi patients over 4 years. One death over a 12-year period was reported in the 22 patients from Saudi Arabia. Partial splenectomy was associated with a dramatic reduction of mortality in the Iraqi patients. None of the 12 patients died during a follow-up period of 4 years.
Pneumovax is a powerful prophylactic tool against overwhelming postsplenectomy infection in patients with thalassaemia and should be used whenever available. In poor or problematic countries with limited health resources, partial rather than total splenectomy could offer an alternative measure to avoid this fatal complication.
我们旨在评估在无法采取其他预防措施的情况下,部分脾切除术与全脾切除术对地中海贫血患者败血症的保护作用。脾切除术后暴发性感染是这些患者脾切除术后的严重并发症,多数表现为肺炎球菌败血症。术前给予肺炎球菌疫苗是一种公认的预防措施。
在本研究中,我们比较了来自伊拉克和沙特阿拉伯的两组地中海贫血脾切除术患者。所有沙特阿拉伯患者均接受了术前肺炎球菌疫苗接种,并在约4周后接受了全脾切除术。不幸的是,伊拉克患者无法获得这种疫苗。作为预防这种致命并发症的保护措施,许多伊拉克患者接受了部分脾切除术。
两组全脾切除术的死亡率存在显著差异。4年间,30例登记的伊拉克患者中有5例死亡。沙特阿拉伯的22例患者在12年期间报告有1例死亡。部分脾切除术使伊拉克患者的死亡率显著降低。12例患者在4年随访期内均未死亡。
肺炎球菌疫苗是预防地中海贫血患者脾切除术后暴发性感染的有力预防工具,应在有条件时使用。在卫生资源有限的贫穷或问题国家,部分脾切除术而非全脾切除术可为避免这种致命并发症提供一种替代措施。